Angelica sinensis: A Chinese herb for brain cancer therapy

Kim, 2002, The radioprotective effects of bu-zhong-yi-qi-tang: a prescription of traditional Chinese medicine, Am J Chin Med, 30, 127, 10.1142/S0192415X02000144 Wang, 2001, Effects of an angelica extract on human erythrocyte aggregation, deformation and osmotic fragility, Clin Hemorheol Microcirc, 24, 201 Xie, 2001, An experimental study on drugs for improving blood circulation and removing blood stasis in treating mild chronic hepatic damage, J Tradit Chin Med, 21, 225 Yim, 2000, Myocardial protection against ischaemia-reperfusion injury by a Polygonum multiflorum extract supplemented ‘Dang-Gui decoction for enriching blood’, a compound formulation, ex vivo, Phytother Res, 14, 195, 10.1002/(SICI)1099-1573(200005)14:3<195::AID-PTR629>3.0.CO;2-4 Ye, 2001, Angelica sinensis modulates migration and proliferation of gastric epithelial cells, Life Sci, 68, 961, 10.1016/S0024-3205(00)00994-2 Ye, 2001, Protective effect of polysaccharides-enriched fraction from Angelica sinensis on hepatic injury, Life Sci, 69, 637, 10.1016/S0024-3205(01)01153-5 Ye, 2001, A mechanistic study of proliferation induced by Angelica sinensis in a normal gastric epithelial cell line, Biochem Pharmacol, 61, 1439, 10.1016/S0006-2952(01)00625-6 Ye, 2003, Effect of polysaccharides from Angelica sinensis on gastric ulcer healing, Life Sci, 72, 925, 10.1016/S0024-3205(02)02332-9 Schwartsmann, 2002, Anticancer drug discovery and development throughout the world, J Clin Oncol, 20, 47S Zhao, 2003, Molecular genetic and chemical assessment of radix Angelica (Danggui) in China, J Agric Food Chem, 51, 2576, 10.1021/jf026178h Chen, 2007, Cytotoxic constituents from angelicae sinensis radix, Arch Pharm Res, 30, 565, 10.1007/BF02977650 Li, 2011, Synthesis of ferulic acid derivatives and their inhibitory effect on platelet aggregation, Yao Xue Xue Bao, 46, 305 Yin, 1980, The effect of Dang-Gui (Angelica sinensis) and its ingredient ferulic acid on rat platelet aggregation and release of 5-HT (author’s translation), Yao Xue Xue Bao, 15, 321 Zhong, 2007, Protection of Angelica sinensis against radiation-induced pulmonary fibrosis in mice, Zhonghua Yu Fang Yi Xue Za Zhi, 41, 105 Xie, 2006, Chinese medicine Angelica sinensis suppresses radiation-induced expression of TNF-alpha and TGF-beta1 in mice, Oncol Rep, 15, 1429 Han, 2006, Regulation of Nur77 nuclear export by c-Jun N-terminal kinase and Akt, Oncogene, 25, 2974, 10.1038/sj.onc.1209358 Cheng, 2004, Acetone extract of Angelica sinensis inhibits proliferation of human cancer cells via inducing cell cycle arrest and apoptosis, Life Sci, 75, 1579, 10.1016/j.lfs.2004.03.009 Lee, 2006, Biological inhibitory effects of the Chinese herb danggui on brain astrocytoma, Pathobiology, 73, 141, 10.1159/000095560 Choy, 1994, Immunopharmacological studies of low molecular weight polysaccharide from Angelica sinensis, Am J Chin Med, 22, 137, 10.1142/S0192415X94000176 Cao, 2006, Structural analysis of water-soluble glucans from the root of Angelica sinensis (Oliv.) Diels, Carbohydr Res, 341, 1870, 10.1016/j.carres.2006.04.017 Cao, 2010, Characterizations and anti-tumor activities of three acidic polysaccharides from Angelica sinensis (Oliv.) Diels, Int J Biol Macromol, 46, 115, 10.1016/j.ijbiomac.2009.11.005 Tsai, 2006, The natural compound n-butylidenephthalide derived from Angelica sinensis inhibits malignant brain tumor growth in vitro and in vivo, J Neurochem, 99, 1251, 10.1111/j.1471-4159.2006.04151.x Mullady, 2004, A phthalide with in vitro growth inhibitory activity from an oidiodendron strain, J Nat Prod, 67, 2086, 10.1021/np040123n Yoshikawa, 2010, Novel phthalide compounds from Sparassis crispa (Hanabiratake), Hanabiratakelide A-C, exhibiting anti-cancer related activity, Biol Pharm Bull, 33, 1355, 10.1248/bpb.33.1355 Zheng, 1993, Chemoprevention of benzo[a]pyrene-induced forestomach cancer in mice by natural phthalides from celery seed oil, Nutr Cancer, 19, 77, 10.1080/01635589309514238 Kan, 2008, Study of the anti-proliferative effects and synergy of phthalides from Angelica sinensis on colon cancer cells, J Ethnopharmacol, 120, 36, 10.1016/j.jep.2008.07.027 Yu, 2010, Extended O6-methylguanine methyltransferase promoter hypermethylation following n-butylidenephthalide combined with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) on inhibition of human hepatocellular carcinoma cell growth, J Agric Food Chem, 58, 1630, 10.1021/jf903043r Bonham, 2002, Molecular effects of the herbal compound PC-SPES: identification of activity pathways in prostate carcinoma, Cancer Res, 62, 3920 Giese, 2003, Cost of migration: invasion of malignant gliomas and implications for treatment, J Clin Oncol, 21, 1624, 10.1200/JCO.2003.05.063 Hu, 2002, Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell, Int J Cancer, 102, 250, 10.1002/ijc.10707 Kao, 2001, The Chinese medicine Bu-Zhong-Yi-Qi-Tang inhibited proliferation of hepatoma cell lines by inducing apoptosis via G0/G1 arrest, Life Sci, 69, 1485, 10.1016/S0024-3205(01)01226-7 Lee, 2002, Paeoniae Radix, a Chinese herbal extract, inhibit hepatoma cells growth by inducing apoptosis in a p53 independent pathway, Life Sci, 71, 2267, 10.1016/S0024-3205(02)01962-8 Yano, 1994, The herbal medicine sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase, Cancer Res, 54, 448 Tsai, 2005, The antitumor effects of Angelica sinensis on malignant brain tumors in vitro and in vivo, Clin Cancer Res, 11, 3475, 10.1158/1078-0432.CCR-04-1827 Ross, 1998, Contributions of cell kill and posttreatment tumor growth rates to the repopulation of intracerebral 9L tumors after chemotherapy: an MRI study, Proc Natl Acad Sci U S A, 95, 7012, 10.1073/pnas.95.12.7012 Bardon, 2002, Monoterpenes inhibit proliferation of human colon cancer cells by modulating cell cycle-related protein expression, Cancer Lett, 181, 187, 10.1016/S0304-3835(02)00047-2 Bello, 2001, Low-dose chemotherapy combined with an antiangiogenic drug reduces human glioma growth in vivo, Cancer Res, 61, 7501 Blacklock, 1986, Drug streaming during intra-arterial chemotherapy, J Neurosurg, 64, 284, 10.3171/jns.1986.64.2.0284 Cobb, 1996, Significance of proliferating cell nuclear antigen in predicting recurrence of intracranial meningioma, J Neurosurg, 84, 85, 10.3171/jns.1996.84.1.0085 Elliott, 1996, Unlocking the blood-brain barrier: a role for RMP-7 in brain tumor therapy, Exp Neurol, 141, 214, 10.1006/exnr.1996.0156 Mahaley, 1989, National survey of patterns of care for brain-tumor patients, J Neurosurg, 71, 826, 10.3171/jns.1989.71.6.0826 Santarius, 1997, Molecular aspects of neuro-oncology, Clin Neurol Neurosurg, 99, 184, 10.1016/S0303-8467(97)00025-5 Chen, 2008, The induction of orphan nuclear receptor Nur77 expression by n-butylenephthalide as pharmaceuticals on hepatocellular carcinoma cell therapy, Mol Pharmacol, 74, 1046, 10.1124/mol.107.044800 Lin, 2008, Orphan nuclear receptor, Nurr-77 was a possible target gene of butylidenephthalide chemotherapy on glioblastoma multiform brain tumor, J Neurochem, 106, 1017, 10.1111/j.1471-4159.2008.05432.x Lin, 2011, Butylidenephthalide suppresses human telomerase reverse transcriptase (TERT) in human glioblastomas, Ann Surg Oncol, 10.1245/s10434-011-1644-0 Li, 2000, Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3, Science, 289, 1159, 10.1126/science.289.5482.1159 Williams, 1993, Activation of the inducible orphan receptor gene nur77 by serum growth factors: dissociation of immediate-early and delayed-early responses, Mol Cell Biol, 13, 6124, 10.1128/MCB.13.10.6124 Winoto, 2002, Nuclear hormone receptors in T lymphocytes, Cell, 109, S57, 10.1016/S0092-8674(02)00710-9 Woronicz, 1994, Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas, Nature, 367, 277, 10.1038/367277a0 Li, 2006, NR4A1, 2, 3 – an orphan nuclear hormone receptor family involved in cell apoptosis and carcinogenesis, Histol Histopathol, 21, 533 Lin, 2004, Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3, Cell, 116, 527, 10.1016/S0092-8674(04)00162-X Wilson, 2003, TR3/Nur77 in colon cancer cell apoptosis, Cancer Res, 63, 5401 Youn, 1999, Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2, Science, 286, 790, 10.1126/science.286.5440.790 Chintharlapalli, 2005, Activation of Nur77 by selected 1,1-Bis(3’-indolyl)-1-(p-substituted phenyl)methanes induces apoptosis through nuclear pathways, J Biol Chem, 280, 24903, 10.1074/jbc.M500107200 Rajpal, 2003, Transcriptional activation of known and novel apoptotic pathways by Nur77 orphan steroid receptor, EMBO J, 22, 6526, 10.1093/emboj/cdg620 Weih, 1996, Apoptosis of nur77/N10-transgenic thymocytes involves the Fas/Fas ligand pathway, Proc Natl Acad Sci U S A, 93, 5533, 10.1073/pnas.93.11.5533 Liu, 2002, Induction of apoptosis by TPA and VP-16 is through translocation of TR3, World J Gastroenterol, 8, 446, 10.3748/wjg.v8.i3.446 Kim, 2005, Menin represses JunD transcriptional activity in protein kinase C theta-mediated Nur77 expression, Exp Mol Med, 37, 466, 10.1038/emm.2005.57 Flores, 2006, Telomerase regulation and stem cell behaviour, Curr Opin Cell Biol, 18, 254, 10.1016/j.ceb.2006.03.003 Wu, 1999, Direct activation of TERT transcription by c-MYC, Nat Genet, 21, 220, 10.1038/6010 Kyo, 2000, Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT), Nucleic Acids Res, 28, 669, 10.1093/nar/28.3.669 Coates, 2007, Beryllium induces premature senescence in human fibroblasts, J Pharmacol Exp Ther, 322, 70, 10.1124/jpet.106.118018